32 investors have funded 8 Life Sciences companies head-officed in Bridgewater, across 32 rounds (Dec 1998 – Jul 2024). They are ranked by how many Bridgewater companies in this market they have actually backed.
"In Bridgewater" describes the companies, not the investor: most of the money in any city comes from somewhere else, and the Where the money comes from section below shows exactly where it came from here.
Ranked by companies backed in this market and city, then by round count. "Led" counts rounds recorded with this investor as lead.
| # | Investor | Based in | Stages here | Companies | Rounds | Led | Latest | Portfolio total |
|---|---|---|---|---|---|---|---|---|
| 1 | Canaan | San Francisco, United States | Series C | 1 | 1 | — | Dec 1998 | 379 |
| 2 | F-Prime Capital | Cambridge, United States | Seed | 1 | 1 | — | Jan 2015 | 306 |
| 3 | Pitango | Herzliya, Israel | Series C | 1 | 1 | — | Sep 2011 | 176 |
| 4 | Oak Investment Partners | Greenwich, United States | Series C | 1 | 1 | — | Dec 1998 | 179 |
| 5 | IndieBio | San Francisco, United States | Seed | 1 | 1 | 1 | Oct 2020 | 252 |
| 6 | Domain Associates | Princeton, United States | Series C | 1 | 1 | — | Dec 1998 | 117 |
| 7 | MPM Capital | Boston | Series C | 1 | 1 | — | Sep 2011 | 127 |
| 8 | Frazier Healthcare Partners | Seattle, United States | Series C | 1 | 1 | — | Dec 1998 | 118 |
| 9 | Advanced Technology Ventures | Menlo Park, United States | Series C | 1 | 1 | — | Sep 2011 | 87 |
| 10 | Abingworth | London, United Kingdom | Series C | 1 | 1 | — | Sep 2011 | 98 |
| 11 | WestBridge Capital | Quatre Bornes, Mauritius | Series C | 1 | 1 | — | Oct 2003 | 88 |
| 12 | 360 One | Mumbai, India | Series A | 1 | 1 | 1 | Mar 2022 | 89 |
| 13 | Kaiser Permanente Ventures | Oakland, United States | Series C | 1 | 1 | — | Sep 2011 | 67 |
| 14 | ONSET Ventures | Menlo Park, United States | Series C | 1 | 1 | — | Sep 2011 | 51 |
| 15 | HLM Venture Partners | Waltham, United States | Series C | 1 | 1 | — | Sep 2011 | 62 |
| 16 | Healthcap | Stockholm, Sweden | Series C | 1 | 1 | — | Dec 1998 | 68 |
| 17 | TL Ventures | Wayne, United States | Series C | 1 | 1 | — | Dec 1998 | 54 |
| 18 | Everstone Capital | Singapore, Singapore | Series A | 1 | 1 | 1 | Dec 2016 | 42 |
| 19 | CHL Medical Partners | Westport, United States | Series C | 1 | 1 | — | Sep 2011 | 28 |
| 20 | Welsh, Carson, Anderson & Stowe | New York City, United States | Series C | 1 | 1 | 1 | Sep 2011 | 31 |
| 21 | Access Biotechnology | New York City, United States | Post-IPO | 1 | 1 | 1 | Nov 2023 | 22 |
| 22 | CRG | Houston, United States | Post-IPO | 1 | 1 | — | May 2016 | 15 |
| 23 | Beacon Angels | Boston, United States | Seed | 1 | 1 | 1 | Jan 2022 | 14 |
| 24 | Agate | Tel Aviv, Israel | Series C | 1 | 1 | — | Sep 2011 | 12 |
| 25 | Montrose Capital Partners | Miami, United States | Post-IPO | 1 | 1 | — | May 2016 | 13 |
| 26 | Maroon Venture Partners | Amherst, United States | Seed | 1 | 1 | 1 | Jan 2022 | 5 |
| 27 | Kohli And Bhargava Family Trust | Series A | 1 | 1 | — | Jul 2023 | 4 | |
| 28 | Brahmaahr Creation | Series A | 1 | 1 | — | Jul 2023 | 3 | |
| 29 | Double Arrow Consultancy | Series A | 1 | 1 | — | Jul 2023 | 2 | |
| 30 | Hourglass Venture Partners | Palo Alto, United States | Series A | 1 | 1 | 1 | Jul 2024 | 2 |
| 31 | STARMed | Goyang, South Korea | Seed | 1 | 1 | 1 | Jan 2022 | 1 |
| 32 | Shekama | Series A | 1 | 1 | 1 | Jul 2023 | 1 |
Head office of the investors on this page.
Rounds by stage — where in a company's life this money arrives.
Total disclosed size of each round, not one investor's share.
How active this market has been.
Life Sciences companies head-officed in Bridgewater that took money from these investors.
| Company | Backers | Rounds | Disclosed | Latest round |
|---|---|---|---|---|
| Valeritas valeritas.com |
12 | 12 | $1.6B | Post-IPO May 2016 |
| OraPharma orapharma.com |
6 | 6 | $96M | Series C Dec 1998 |
| OmniActive omniactives.com |
6 | 6 | $41.2M | Series A Jul 2023 |
| Theromics theromicsinc.com |
3 | 3 | $6M | Seed Jan 2022 |
| VYNE Therapeutics vynetherapeutics.com |
2 | 2 | $88.2M | Post-IPO Nov 2023 |
| marketRx marketrx.com |
1 | 1 | $10.3M | Series C Oct 2003 |
| JOGO jogohealth.com |
1 | 1 | $5.5M | Series A Jul 2024 |
| Cayuga Biotech cayugabiotech.com |
1 | 1 | $250K | Seed Oct 2020 |
| Date | Investor | Company | Stage | Round size |
|---|---|---|---|---|
| Jul 2024 | Hourglass Venture PartnersLED | JOGO | Series A | $5.5M |
| Nov 2023 | Access BiotechnologyLED | VYNE Therapeutics | Post-IPO | $88.2M |
| Jul 2023 | Kohli And Bhargava Family Trust | OmniActive | Series A | $1.6M |
| Jul 2023 | Double Arrow Consultancy | OmniActive | Series A | $1.6M |
| Jul 2023 | Brahmaahr Creation | OmniActive | Series A | $1.6M |
| Jul 2023 | ShekamaLED | OmniActive | Series A | $1.6M |
| Mar 2022 | 360 OneLED | OmniActive | Series A | — |
| Jan 2022 | Beacon AngelsLED | Theromics | Seed | $2M |
| Jan 2022 | Maroon Venture PartnersLED | Theromics | Seed | $2M |
| Jan 2022 | STARMedLED | Theromics | Seed | $2M |
| Oct 2020 | IndieBioLED | Cayuga Biotech | Seed | $250K |
| Dec 2016 | Everstone CapitalLED | OmniActive | Series A | $35M |
| May 2016 | Montrose Capital Partners | Valeritas | Post-IPO | $25.2M |
| May 2016 | CRG | Valeritas | Post-IPO | $25.2M |
| Jan 2015 | F-Prime Capital | VYNE Therapeutics | Seed | — |
| Sep 2011 | MPM Capital | Valeritas | Series C | $150M |
| Sep 2011 | Abingworth | Valeritas | Series C | $150M |
| Sep 2011 | Agate | Valeritas | Series C | $150M |
| Sep 2011 | Pitango | Valeritas | Series C | $150M |
| Sep 2011 | ONSET Ventures | Valeritas | Series C | $150M |
Life Sciences investors in other cities